Sort
48,018 grants matching “immunotherapy”
Embryonic natural killer cell development and function
$579,358Christopher Michael Sturgeon · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · HL
Follistatin-like 1 Mediated Host Defense in Bacterial Pneumonia
$579,321Brian T Campfield · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · HL
Follistatin-like 1 Mediated Host Defense in Bacterial Pneumonia
$579,321Brian T Campfield · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · HL
Follistatin-like 1 Mediated Host Defense in Bacterial Pneumonia
$579,321Brian T Campfield · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · HL
Cellular & Inflammatory Pathways in Ashtma & Allergic Diseases: From IgE to Cells
$579,311Lawrence Barry Schwartz · Virginia Commonwealth University · U19 · FY2009 · AI
Targeting the Immune System in Mouse Models of Lung Adenocarcinoma
$579,271Katerina Abigail Politi · Yale University · R01 · FY2017 · CA
Disrupted Circadian Regulation of Cell Migration at CNS-Immune Interfaces in Aging and Alzheimer's Disease
$579,264Laura K Fonken · University Of Texas At Austin · R01 · FY2022 · AG
Homologous recombination deficiency and beyond in pancreatic cancer: evaluating the regulators of response to pembrolizumab and olaparib (POLAR) from the immune and genomic perspectives
$579,257Eileen Mary O'Reilly · Sloan-Kettering Inst Can Research · P50 · FY2024 · CA
HIFU-immunotherapy in pancreatic cancer
$579,183Katherine W Ferrara · Stanford University · R01 · FY2024 · CA
Identify the host genetic determinants of immune response and TB countrol
$579,162Ildiko Vanrhijn · Brigham And Women'S Hospital · U19 · FY2021 · AI
TLR Immunotherapy to Eradicate Anatomic SIV Reservoirs
$579,143James Burton Whitney · Beth Israel Deaconess Medical Center · R01 · FY2019 · AI
Improving CAR-T efficacy against solid tumors by expanding lymph node reservoirs of âstem-likeâ CAR-T cells
$579,054Shivani Srivastava · Fred Hutchinson Cancer Center · R37 · FY2023 · CA
Cooperation of the TAM and Abl family kinases in therapeutic resistance in HNC
$579,028Deric L Wheeler · University Of Wisconsin-Madison · R01 · FY2023 · CA
Influences of the Microenvironment on Cancer Stem Cells
$579,004Hong Wu · University Of California Los Angeles · U01 · FY2014 · CA
Developing a translational pipeline for NF1-mutant malignancies
$578,917Karen M Cichowski · Brigham And Women'S Hospital · U01 · FY2016 · CA
Polyamines and Hypusine in Type 1 Diabetes Pathogenesis
$578,915Raghavendra G Mirmira · University Of Chicago · R01 · FY2025 · DK
Tumor-penetrating nano-theranostics for image-guided interventions in spontaneous feline head and neck cancer
$578,900Yuanpei Li · University Of California At Davis · R01 · FY2021 · DE
Elucidation of Human Natural Killer Cell Development
$578,825Aharon G Freud · Ohio State University · R01 · FY2023 · CA
Trispecific CAR-T cells targeting CD19, CD20 and CD22 to treat B-cell malignancies
$578,809Sumithira Vasu · Ohio State University · R01 · FY2024 · CA
Delineating Functional Immunity via Image-Guided PET
$578,749Nerissa Therese Viola · Wayne State University · R37 · FY2023 · CA
Molecular Control of Plasmacytoid Dendritic Cell Development and Function
$578,680Boris Reizis · New York University School Of Medicine · R37 · FY2020 · AI
Escape from CAR T surveillance through lineage plasticity
$578,670Patricia A Ernst · University Of Colorado Denver · R01 · FY2022 · CA
Endothelial-Leukocyte Adhesion in CAR T Cell Treatment Associated Neurotoxicity
$578,662Juliane Gust · Seattle Children'S Hospital · R37 · FY2025 · CA
Testing the role of BATF as a pioneer transcription factor in effector T cells
$578,656Cigall Kadoch · Dana-Farber Cancer Inst · R01 · FY2018 · AI
Project 2: Local immunotherapy corrects chemokine patterns in ovarian cancer
$578,652Robert Page Edwards · Roswell Park Cancer Institute Corp · P01 · FY2020 · CA